[{"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA103172"], "brand_name": ["CATHFLO ACTIVASE"], "generic_name": ["ALTEPLASE"], "manufacturer_name": ["Genentech, Inc."], "product_ndc": ["50242-041"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["ALTEPLASE"], "spl_id": ["5a8d3873-0072-421b-b244-e1801c097703"], "spl_set_id": ["91ecdef2-95ff-42dd-a31c-c8a09cab3ad9"], "package_ndc": ["50242-041-64", "50242-041-10"], "is_original_packager": [true], "unii": ["1RXS4UE564"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0476-2021", "product_description": "cathflo activase (ALTEPLASE) 2 mg Rx Only NDC 50242-041-64 Genentech", "product_quantity": "1473 vials", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "3410425"}, {"status": "Terminated", "city": "Newark", "state": "DE", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "88617", "recalling_firm": "DuPont Nutrition USA, Inc", "address_1": "1301 Ogletown Rd", "address_2": "", "postal_code": "19711-5419", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to one account that may have used it as a component in finished drug formulations, and further distributed Nationwide in the USA.", "recall_number": "D-0830-2021", "product_description": "Avicel RC-591 NF (MCC/Carboxymethylcellulose Sodium) NF, bulk powder, 80.0 KG drum, Manufactured by: DuPont Nutrition USA, Inc., 1301 Ogletown Road, Newark, DE 19711", "product_quantity": "80 kg", "reason_for_recall": "Microbial Contamination of Non-Sterile Product: Out-of-specification results obtained for total aerobic microbial count (TAMC).", "recall_initiation_date": "20210827", "center_classification_date": "20210923", "termination_date": "20220311", "report_date": "20210929", "code_info": "Lot # 2173766940", "more_code_info": ""}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["ROMPE PECHO"], "generic_name": ["GUAIFENESIN"], "manufacturer_name": ["Efficient Laboratories Inc"], "product_ndc": ["58593-829"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["GUAIFENESIN"], "rxcui": ["310604", "1112205"], "spl_id": ["26e4f72a-b911-8dc6-e063-6394a90a4326"], "spl_set_id": ["89ea23a5-0da7-407e-83d9-77a0b562f3af"], "package_ndc": ["58593-829-06", "58593-829-04"], "is_original_packager": [true], "nui": ["N0000193956", "N0000008867", "N0000009560"], "pharm_class_epc": ["Expectorant [EPC]"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "unii": ["495W7451VQ"]}, "product_type": "Drugs", "event_id": "89205", "recalling_firm": "Efficient Laboratories, Inc.", "address_1": "7715 NW 64th St", "address_2": "N/A", "postal_code": "33166-2719", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0292-2022", "product_description": "Rompe Pecho Ex Expectorant,  packaged in a) 4 Fl. Oz. (118 mL) bottles NDC 58593-829-04 and b) 6 Fl. Oz. (178 mL) bottles NDC 58593-829-06, Distributed by Efficient Laboratories, Inc. Miami, FL 33166", "product_quantity": "a) 7,800 bottles; b) 16,417 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products", "recall_initiation_date": "20210824", "center_classification_date": "20211222", "termination_date": "20221208", "report_date": "20211229", "code_info": "Lot #: a) 19H20 Exp. August 2022; 19A418 Exp. January 2022; 19E411 Exp. May 2022; b) 19H20 Exp. August 2022; 19J98 Exp. September 2022; 19A418 Exp. January 2022; 19E411 Exp. May 2022"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA091650"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-121", "55111-122", "55111-123"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["617310", "617311", "617312"], "spl_id": ["36e09eff-3948-2638-b633-d5ec2bc03d2a"], "spl_set_id": ["901550e6-22be-68c9-eb86-f85a9c9dd998"], "package_ndc": ["55111-121-30", "55111-121-60", "55111-121-90", "55111-121-05", "55111-121-10", "55111-122-30", "55111-122-60", "55111-122-90", "55111-122-05", "55111-122-10", "55111-123-30", "55111-123-60", "55111-123-90", "55111-123-05", "55111-123-10"], "is_original_packager": [true], "upc": ["0355111123903"], "unii": ["48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "88041", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0629-2021", "product_description": "Atorvastatin Calcium Tablets, USP 10 mg, 500-count bottles, Rx Only, Dr. Reddy's Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally, 500-090 India, NDC 55111-121-05.", "product_quantity": "5984 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: due to presence of ATV cyclo IP and FP impurities", "recall_initiation_date": "20210604", "center_classification_date": "20210611", "termination_date": "20230216", "report_date": "20210623", "code_info": "Lot #: C905064, C905065, Exp. Date 07/2021", "more_code_info": ""}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA018801"], "brand_name": ["STERILE WATER"], "generic_name": ["WATER"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-4887"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["WATER"], "spl_id": ["900859c0-a075-4fb1-98ce-0e329acc009a"], "spl_set_id": ["2b9ea23a-f9e9-48a8-25b7-519e3bbd6828"], "package_ndc": ["0409-4887-25", "0409-4887-99", "0409-4887-31", "0409-4887-05", "0409-4887-17", "0409-4887-10", "0409-4887-32", "0409-4887-34", "0409-4887-23", "0409-4887-20", "0409-4887-24", "0409-4887-50"], "is_original_packager": [true], "unii": ["059QF0KO0R"]}, "product_type": "Drugs", "event_id": "87831", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0384-2021", "product_description": "Sterile Water for Inj., USP, 25 x 100 mL Single Dose Vials per carton, Rx only, For Drug Diluent Use Only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA, NDC Carton: 0409-4887-99; NDC Vial: 0409-4887-25", "product_quantity": "49,525 vials", "reason_for_recall": "Presence of Particulate Matter: particulate matter identified as an insect in one vial.", "recall_initiation_date": "20210503", "center_classification_date": "20210514", "termination_date": "20230729", "report_date": "20210526", "code_info": "Lot DN9185"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87981", "recalling_firm": "Miracle 8989", "address_1": "2001 W Northwest Hwy", "address_2": "N/A", "postal_code": "75220-2350", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0634-2021", "product_description": "PremierZEN Platinum 8000 capsule, 1-count blister card (UPC 7 28175 42185 6), packaged in 12 cards per box (UPC 7 28175 42183 2), Distributed by: New Premier Group, Los Angeles, CA  90006", "product_quantity": "Unknown", "reason_for_recall": "Marketed without an approved NDA/ANDA - Product found to be tainted with Sildenafil and Tadalafil.", "recall_initiation_date": "20210518", "center_classification_date": "20210622", "termination_date": "20230712", "report_date": "20210630", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Palisades Park", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87624", "recalling_firm": "Ummzy, LLC", "address_1": "273 5th St", "address_2": "Unit A", "postal_code": "07650-2088", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0663-2021", "product_description": "Shogun-X capsules, 10-count boxes, Manufactured by Power Life Distributors, Made in USA, UPC 118122030185", "product_quantity": "364 boxes/10 capsules per box", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Products found to contain undeclared tadalafil and/ or sildenafil and vardenafil making them unapproved drugs for which the safety and efficacy have not been established and therefore subject to recall.", "recall_initiation_date": "20210330", "center_classification_date": "20210716", "termination_date": "20220609", "report_date": "20210728", "code_info": "All lots within expiry.", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA205836"], "brand_name": ["BRIVIACT"], "generic_name": ["BRIVARACETAM"], "manufacturer_name": ["UCB, Inc."], "product_ndc": ["50474-370", "50474-470", "50474-570", "50474-670", "50474-770", "50474-870", "50474-970"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BRIVARACETAM"], "rxcui": ["1739749", "1739754", "1739761", "1739766", "1739768", "1739770", "1739772", "1739774", "1739776", "1739778", "1739780", "1739782", "1739785", "1739788"], "spl_id": ["3e7903ad-236d-1a65-e063-6294a90a6f44"], "spl_set_id": ["3cf2f439-0e97-443e-8e33-25ecef616f6c"], "package_ndc": ["50474-370-66", "50474-470-66", "50474-470-09", "50474-470-14", "50474-570-66", "50474-570-09", "50474-570-14", "50474-670-66", "50474-770-66", "50474-770-09", "50474-770-14", "50474-870-15", "50474-970-63", "50474-970-75"], "is_original_packager": [true], "nui": ["N0000192345"], "pharm_class_moa": ["Epoxide Hydrolase Inhibitors [MoA]"], "unii": ["U863JGG2IA"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0591-2021", "product_description": "Briviact (brivaracetam) tablets 50 mg, 60-count bottle, Rx only Manufactured for UCB, Inc. Smyrna, GA 30080, NDC 50474-570-66", "product_quantity": "101 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "309750"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88823", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W Field Ct Ste 300", "address_2": "", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0004-2022", "product_description": "Betaxolol Ophthalmic Solution, USP, 0.5%, (Betaxolol HCl 5.6 mg/mL), 5 mL dropper bottle, Rx only, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045.  Carton NDC: 17478-705-10, Bottle NDC 17478-705-11", "product_quantity": "10,210 bottles", "reason_for_recall": "Microbial Contamination of Sterile Products: Confirmed sterility failure identified during stability testing at the 12-month time point.", "recall_initiation_date": "20211004", "center_classification_date": "20211007", "termination_date": "20220817", "report_date": "20211013", "code_info": "Lot 0B61A, Exp 01/31/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["NOHIST DM"], "generic_name": ["CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE AND PHENYLEPHRINE HYDROCHLORIDE"], "manufacturer_name": ["Larken Laboratories, Inc."], "product_ndc": ["68047-186"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPHENIRAMINE MALEATE", "DEXTROMETHORPHAN HYDROBROMIDE", "PHENYLEPHRINE HYDROCHLORIDE"], "rxcui": ["1086443"], "spl_id": ["41481ef6-a5df-3f15-e063-6294a90a1bda"], "spl_set_id": ["6aafe912-28ff-442f-8e07-b3c5993ac943"], "package_ndc": ["68047-186-16"], "is_original_packager": [true], "upc": ["0368047186164"], "unii": ["V1Q0O9OJ9Z", "9D2RTI9KYH", "04JA59TNSJ"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0507-2021", "product_description": "NOHIST-DM Antihistamine/Antitussive Nasal Decongestant 16 fl. oz. (473 mL) NDC 68047-186-16 Distributed by: Larken Laboratories, Inc. Canton, MS 39046", "product_quantity": "24 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "87266", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0340-2021", "product_description": "Betamethasone Dipropionate Ointment USP, 0.05% (Augmented), packaged in 15 grams tubes, Manufactured by: Teligent Pharma, Inc. Buena, New Jersey 08310, Distributed by: McKesson Corporation dba Sky Packaging 4971 Southbridge Blvd., Suite 101 Memphis, TN 38141, NDC 63739-996-15", "product_quantity": "N/A", "reason_for_recall": "Failed Impurities/ Degradation Specifications -  OOS for know impurity Betamethasone 17- propionate.", "recall_initiation_date": "20210202", "center_classification_date": "20210423", "termination_date": "20240815", "report_date": "20210505", "code_info": "Lot #: 15644, Exp 5/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88693", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "494 patients/consumers received prescriptions and are located in AZ, CA FL, MN, MT, TX, and UT.", "recall_number": "D-0045-2022", "product_description": "TEST CYP 25MG/ML IN ETHYL OLEATE MDV, Rx only, Red Mountain Compounding Rx", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns", "recall_initiation_date": "20210813", "center_classification_date": "20211026", "termination_date": "20230412", "report_date": "20211103", "code_info": "all lots within expiry"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020186"], "brand_name": ["BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE"], "generic_name": ["BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-3241", "0093-3242", "0093-3243"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BISOPROLOL FUMARATE", "HYDROCHLOROTHIAZIDE"], "rxcui": ["854908", "854916", "854919"], "spl_id": ["e67411e1-0823-4876-a456-cbf397c24086"], "spl_set_id": ["27d52b23-e3e2-4339-b00e-cd0fec43ffbb"], "package_ndc": ["0093-3241-01", "0093-3242-01", "0093-3243-56"], "is_original_packager": [true], "upc": ["0300933241014", "0300933243568"], "nui": ["N0000175359", "N0000175419", "M0471776"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "unii": ["UR59KN573L", "0J48LPH2TH"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0575-2021", "product_description": "BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE TABLETS 2.5 mg/6.25 mg, 100-count bottles, Rx Only, Distributed by: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054 NDC 0093-3241-01 RX; TABLETS", "product_quantity": "235 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "1417295A"}, {"status": "Terminated", "city": "South Beloit", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M013"], "brand_name": ["ACETAMINOPHEN"], "generic_name": ["ACETAMINOPHEN"], "manufacturer_name": ["Precision Dose, Inc."], "product_ndc": ["68094-030", "68094-231", "68094-330"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN"], "rxcui": ["307668"], "spl_id": ["969e07e8-8e42-47bc-a77b-0ff7893d3175"], "spl_set_id": ["e1d4f562-433c-4344-9b77-1a7c731d1be5"], "package_ndc": ["68094-231-59", "68094-231-62", "68094-231-61", "68094-231-01", "68094-231-58", "68094-330-59", "68094-330-62", "68094-330-61", "68094-030-59", "68094-030-62"], "original_packager_product_ndc": ["0113-0212"], "unii": ["362O9ITL9D"]}, "product_type": "Drugs", "event_id": "88976", "recalling_firm": "Precision Dose Inc.", "address_1": "722 Progressive Ln", "address_2": "N/A", "postal_code": "61080-2616", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0094-2022", "product_description": "Acetaminophen Oral Suspension, 160 mg/5 mL, packaged in 5 mL per cup (NDC Individual cup: 68094-231-59), in a) 30-count case (NDC 30-count case: 68094-231-62), and b) 100-count case (NDC 100-count case: 68094-231-61), Hospital Use Only, Pkg. Precision Dose, Inc., S. Beloit, IL 61080.", "product_quantity": "166,920 unit dose cups", "reason_for_recall": "cGMP Deviations: Product manufactured with contaminated raw ingredient.", "recall_initiation_date": "20211101", "center_classification_date": "20211105", "termination_date": "20240714", "report_date": "20211117", "code_info": "Lot#: 503670", "more_code_info": ""}, {"status": "Terminated", "city": "Livonia", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210614"], "brand_name": ["NIFEDIPINE"], "generic_name": ["NIFEDIPINE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-7081", "0904-7080", "0904-7082"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NIFEDIPINE"], "spl_id": ["af49dd32-02ac-47ab-b513-ca480fe8dc36"], "spl_set_id": ["41aa6fbd-96c1-40f7-92d4-cfdd2d5325e9"], "package_ndc": ["0904-7080-06", "0904-7080-61", "0904-7081-06", "0904-7081-61", "0904-7082-04", "0904-7082-06"], "original_packager_product_ndc": ["50742-260", "50742-261", "50742-262"], "upc": ["0309047080618"], "nui": ["N0000000069", "N0000175421", "M0006414"], "pharm_class_moa": ["Calcium Channel Antagonists [MoA]"], "pharm_class_epc": ["Dihydropyridine Calcium Channel Blocker [EPC]"], "pharm_class_cs": ["Dihydropyridines [CS]"], "unii": ["I9ZF7L6G2L"]}, "product_type": "Drugs", "event_id": "88224", "recalling_firm": "The Harvard Drug Group", "address_1": "17187 N Laurel Park Dr Ste 300", "address_2": "", "postal_code": "48152-2600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed in OH and NJ", "recall_number": "D-0652-2021", "product_description": "NIFEdipine EXTENDED-RELEASE TABLETS, USP 30 mg Rx only packaged as a) 100 count unit dose carton, NDC 0904-7080-61; b) 50 count unit dose carton, NDC 0904-7080-06: Distributed by: Ingenus Pharmaceuticals, LLC Orlando, FL 32839-6408  Distributed by: Major Pharmaceuticals 17177 N Laurel Park Dr., Suite 233 Livonia, MI 48152 USA", "product_quantity": "504 Cartons of 50 count each; 372 Cartons of 100 count each", "reason_for_recall": "Failed Dissolution Specification: Out of specification for dissolution during routine stability testing.", "recall_initiation_date": "20210702", "center_classification_date": "20210709", "termination_date": "20221228", "report_date": "20210721", "code_info": "Lots: a)N00418 Exp. 09/2022, b) N00417 Exp. 09/2022", "more_code_info": ""}, {"country": "United States", "city": "Norwalk", "address_1": "14831 Piuma Ave", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: FDA analysis detected the presence of sibutramine.", "address_2": "", "product_quantity": "591 boxes", "code_info": "Best By Date: 9/2021", "center_classification_date": "20210817", "distribution_pattern": "Distribution Nationwide in the USA via the internet and to the following countries Brazil, Canada, Germany, France, Hong Kong, Italy, Sweden, Switzerland, Thailand, and United Kingdom.", "state": "CA", "product_description": "Vy&Tea (Vietnamese Labeling with a green leaf and a bird underneath) 15/KLT 45.0G (15 tea sachets per box), Manufactured by Havyco No. 45, Group 1, National Highway 14, Son Hiep Hamlet, Tho Son Commune, Bu Dang District, Binh Phuoc Province, Vietnam, Website: trathaomocgiamcan.com.", "report_date": "20210811", "classification": "Class I", "openfda": {}, "recalling_firm": "Qikmoov LLC", "recall_number": "D-0749-2021", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "88280", "more_code_info": "", "recall_initiation_date": "20210714", "postal_code": "90650-5339", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0428-2021", "product_description": "Timolol Maleate Ophthalmic Solution, USP 0.5% 2.5 mL Sterile For Topical Application In The Eye Rx Only NDC 60505-1005-4 Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, FL 33326", "product_quantity": "31 droptainers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "RV7378"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA206073"], "brand_name": ["GLYXAMBI"], "generic_name": ["EMPAGLIFLOZIN AND LINAGLIPTIN"], "manufacturer_name": ["Boehringer Ingelheim Pharmaceuticals, Inc."], "product_ndc": ["0597-0164", "0597-0182"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["EMPAGLIFLOZIN", "LINAGLIPTIN"], "rxcui": ["1602109", "1602115", "1602118", "1602120"], "spl_id": ["b0c37b65-8580-4810-a4e2-08998e82b2b2"], "spl_set_id": ["ddbab689-f76c-488c-9613-4168d41dd730"], "package_ndc": ["0597-0182-70", "0597-0182-07", "0597-0182-03", "0597-0182-30", "0597-0182-39", "0597-0182-90", "0597-0164-30", "0597-0164-39", "0597-0164-90", "0597-0164-70", "0597-0164-07"], "is_original_packager": [true], "nui": ["N0000187059", "N0000187058", "N0000175912", "N0000175913"], "pharm_class_epc": ["Sodium-Glucose Cotransporter 2 Inhibitor [EPC]", "Dipeptidyl Peptidase 4 Inhibitor [EPC]"], "pharm_class_moa": ["Sodium-Glucose Transporter 2 Inhibitors [MoA]", "Dipeptidyl Peptidase 4 Inhibitors [MoA]"], "unii": ["HDC1R2M35U", "3X29ZEJ4R2"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0455-2021", "product_description": "Glyxambi (empagliflozin and linagliptin) Tablets 25 mg/5 mg 30 tablets Rx only NDC 0597-0164-30 Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc. Ridgefield, CT 06877 USA", "product_quantity": "592 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "3513"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0439-2021", "product_description": "AMOXICILLIN 500MG 100; NDC/UPC 65862001401; RX; TABLETS", "product_quantity": "373 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "SE5019062-A"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87298", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA and Puerto Rico.", "recall_number": "D-0274-2021", "product_description": "Epoprostenol Sodium for Injection, 0.5 mg/vial (500,000 ng),  1X10ML vial, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA  19454, NDC 0703-1985-01.", "product_quantity": "12,629 vials", "reason_for_recall": "Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.", "recall_initiation_date": "20210210", "center_classification_date": "20210221", "termination_date": "20240515", "report_date": "20210303", "code_info": "Lot # 31327537B, exp. date 09/2021"}, {"status": "Terminated", "city": "New Paltz", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "88843", "recalling_firm": "Ultra Seal Corporation", "address_1": "521 Main St", "address_2": "N/A", "postal_code": "12561-1609", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0074-2022", "product_description": "North by Honeywell PAIN STOPPER EXTRA STRENGTH (Acetaminophen 250 mg, Aspirin 250 mg, Caffeine 65 mg) tablets, 2 tablets per packet, Packaged in 5,000 Packets/Case, PO# B121242, Item# 853500-01, Dist. By Honeywell Safety Products USA, Smithfield, RI 02917", "product_quantity": "250,000 tablets", "reason_for_recall": "Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.", "recall_initiation_date": "20211013", "center_classification_date": "20211026", "termination_date": "20220328", "report_date": "20211103", "code_info": "Lot #: AK-9371, exp. date 21-Nov"}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88528", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0870-2021", "product_description": "La Core LCL-2-0191 Blend, 149,980ml 20% Alcohol, WHP Homeopathic Medicine, For Manufacturing Only, Liter LCL-2-0191-Bend: 12% Lycopodium Clavatum 10X, 12% Carbo Vegetabilis 16X, 12% Natrum Muriaticum 9X, 12% Calcarea Carbonica 12X, 10% Hypothalamus 30X, 6% Pituitarum Posterium 12X,  6% Pituitarum Posterium 30C, 3% Natrum Phosphoricum 12X, 3% Graphites 30X, 3# Agnus Castus 6X, 3% Thiosinaminum 8X, 3% Phytolacca Decandra 12X, 3% Magnesia Phosphorica 10X, 3% Ornithogalum Umbellatum 6X, 3% Chelidonium Majus 6X, 3% Quercus Robur 14X, 3% Nux Vomica 30X,  Manufactured by Washington Homeopathic Products 260 JR Hawvermale Way, Berkeley Springs, WV, 25411.", "product_quantity": "2/149,980 mL bottles", "reason_for_recall": "Out-of-specification test results obtained for identification testing based on HPTLC analysis.", "recall_initiation_date": "20210820", "center_classification_date": "20210929", "termination_date": "20220621", "report_date": "20211006", "code_info": "Lot # 27861, Exp 8/17/2026"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88693", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "494 patients/consumers received prescriptions and are located in AZ, CA FL, MN, MT, TX, and UT.", "recall_number": "D-0051-2022", "product_description": "VIT B COMPLEX INJ SOLN (HP), Rx only, Red Mountain Compounding Rx", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns", "recall_initiation_date": "20210813", "center_classification_date": "20211026", "termination_date": "20230412", "report_date": "20211103", "code_info": "all lots within expiry"}, {"status": "Terminated", "city": "Venice", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87828", "recalling_firm": "Scentsational Soaps & Candles Inc", "address_1": "730 Commerce Dr", "address_2": "N/A", "postal_code": "34292-1726", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0684-2021", "product_description": "Coconut Stand CoCo TKO Hand Sanitizer, Totally Knocks Out 99.9% of Germs, 3.4 FL. OZ. (100.55 mL), Distributed by: Beauty Sparks LLC St. Petersburg, FL 33711", "product_quantity": "500 bottles", "reason_for_recall": "Chemical contamination: product found to be contaminated with methanol (wood alcohol), benzene and acetaldehyde.", "recall_initiation_date": "20210427", "center_classification_date": "20210719", "termination_date": "20221202", "report_date": "20210728", "code_info": "Lot #: 20260", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090685"], "brand_name": ["POLYETHYLENE GLYCOL 3350"], "generic_name": ["POLYETHYLENE GLYCOL 3350"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "product_ndc": ["45802-868"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["POLYETHYLENE GLYCOL 3350"], "rxcui": ["876193"], "spl_id": ["1a88ad2b-b557-4991-aff2-a1f96159bbdc"], "spl_set_id": ["e138b8c8-48de-48cd-8baa-2cc148cef62c"], "package_ndc": ["45802-868-01", "45802-868-03", "45802-868-02", "45802-868-66"], "is_original_packager": [true], "nui": ["N0000010288", "N0000175811", "N0000009871"], "pharm_class_moa": ["Osmotic Activity [MoA]"], "pharm_class_epc": ["Osmotic Laxative [EPC]"], "pharm_class_pe": ["Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "unii": ["G2M7P15E5P"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0545-2021", "product_description": "POLYETHYLENE GLYCOL 3350 Powder for Solution Osmotic Laxative 14 once-daily doses 14 Packet- Newt Wt. 0.5 oz (17g) each   NDC 45802-868-66", "product_quantity": "934 boxes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Ongoing", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3", "68968-5552-1"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "87980", "recalling_firm": "Noven Pharmaceuticals Inc", "address_1": "11960 Sw 144th St", "address_2": "N/A", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0393-2021", "product_description": "Daytrana (methylphenidate transdermal system), Delivers 10 mg over 9 hours (1.1 mg/hr), 30 Patches (NDC 68968-5552-1) per box (NDC 68968-5552-3), Rx only, Manufactured for Noven Therapeutics, LLC., Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186.", "product_quantity": "9,587 boxes", "reason_for_recall": "Defective Delivery System: The number of customer complaints for ripping patches and tight release/adhesive transfer have exceeded the action limits.", "recall_initiation_date": "20210520", "center_classification_date": "20210524", "report_date": "20210602", "code_info": "Lot: 88528 Exp. 09/2021"}, {"status": "Terminated", "city": "Colchester", "state": "VT", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "87348", "recalling_firm": "Edge Pharma, LLC", "address_1": "856 Hercules Dr", "address_2": "N/A", "postal_code": "05446-8014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0306-2021", "product_description": "Methacholine Challenge 5-Syringe Test Kits, Sterile Inhalation Solution, Preservative Free, 3 mL per syringe, Edge Pharma, LLC, 856 Hercules Dr., Dolchester, VT 06448  NDC # 05446-1600-05", "product_quantity": "213 kits", "reason_for_recall": "Temperature Abuse; labeled with the incorrect room temperature (15-25 \u00bfC) storage conditions rather than the correct refrigerated (2 - 8 \u00bfC) storage conditions", "recall_initiation_date": "20210217", "center_classification_date": "20210318", "termination_date": "20210610", "report_date": "20210324", "code_info": "Lot # 12-2020-16@10, BUD 3-30-21   Lot # 11-2020-18@11, BUD 3-02-21"}, {"status": "Ongoing", "city": "Monterey", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87101", "recalling_firm": "NDAL Mfg Inc.", "address_1": "23745 Spectacular Bid Ln", "address_2": "N/A", "postal_code": "93940-6527", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed Nationwide in the USA and Hong Kong", "recall_number": "D-0269-2021", "product_description": "ManukaGuard Medical Grade Manuka Honey Allercleanse Nasal Spray, 1.3 FL OZ (40mL) bottle, 270 measured sprays, Distributed by Ndal Laboratories, 449 Alvarado St., Monterey, CA 93940 (bottle); NDAL MFG Inc., 80 Garden Court, Suite 100, Monterey, CA  93940 (carton); UPC 8 58631 00212 8.    the Alvarado St. is for the bottle by putting \"(bottle); NDAL MFG Inc., 80 Garden Court, Suite 100, Monterey, CA  93940 (carton); UPC 8 58631 00212 8.\" (according to the label)", "product_quantity": "4265 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Product confirmed to have yeast", "recall_initiation_date": "20201217", "center_classification_date": "20210219", "report_date": "20210303", "code_info": "LOT # 2010045; Best Before 10 2023"}, {"status": "Terminated", "city": "Daphne", "state": "AL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88289", "recalling_firm": "API Solutions Inc.", "address_1": "25309 Friendship Rd", "address_2": "N/A", "postal_code": "36526-6278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "AL, AZ, CO, FL, VA", "recall_number": "D-0696-2021", "product_description": "Azelaic Acid 99.0+% Micro 500 Grams, Distributed By: A.P.I. Solutions Daphne Alabama  Manufactured by: Yicheng Chemicals Corp. China Distributed by: Syntec Pharma Corp New York", "product_quantity": "1 bottle", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20210715", "center_classification_date": "20210728", "termination_date": "20220208", "report_date": "20210804", "code_info": "Lot #: AZA181105, Exp 11/09/2021"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA103941"], "brand_name": ["TUBERSOL"], "generic_name": ["TUBERCULIN PURIFIED PROTEIN DERIVATIVE"], "manufacturer_name": ["Sanofi Pasteur Inc."], "product_ndc": ["49281-752"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRADERMAL"], "substance_name": ["TUBERCULIN PURIFIED PROTEIN DERIVATIVE"], "rxcui": ["313532", "798415"], "spl_id": ["82cb9457-e7b0-47d4-b315-52f39ff9a91e"], "spl_set_id": ["a4a732e9-b8ee-4e6d-8b9a-6a9d2c36bfcd"], "package_ndc": ["49281-752-78", "49281-752-21", "49281-752-98", "49281-752-22"], "is_original_packager": [true], "nui": ["N0000184316", "N0000184315", "N0000184306", "M0001408"], "pharm_class_epc": ["Skin Test Antigen [EPC]", "Tuberculosis Skin Test [EPC]"], "pharm_class_pe": ["Cell-mediated Immunity [PE]"], "pharm_class_cs": ["Antigens, Bacterial [CS]"], "unii": ["I7L8FKN87J"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0566-2021", "product_description": "Tuberculin Purified Protein Derivative (Mantous) TUBERSOL, Stabilized Solution 5 US Units, Rx Only Sanofi Pasteur Limited, NDC 49281-752-21", "product_quantity": "406 vials", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "C5804AA"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87298", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA and Puerto Rico.", "recall_number": "D-0284-2021", "product_description": "MethyIPREDNISolone Acetate Injectable Suspension USP, 400 mg/5 mL (80 mg/mL), 5 mL Multiple-Dose Vial, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA  19454, NDC 0703-0063-01.", "product_quantity": "15,043 vials", "reason_for_recall": "Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.", "recall_initiation_date": "20210210", "center_classification_date": "20210221", "termination_date": "20240515", "report_date": "20210303", "code_info": "Lot # 31327738B, exp. date 03/2021"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87981", "recalling_firm": "Miracle 8989", "address_1": "2001 W Northwest Hwy", "address_2": "N/A", "postal_code": "75220-2350", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0635-2021", "product_description": "maXXzen Platinum 12000 capsule, 1-count blister card (UPC 7 18122 04072 8), Distributed by: Maxx Inc, Los Angeles, CA  90028", "product_quantity": "Unknown", "reason_for_recall": "Marketed without an approved NDA/ANDA - Product found to be tainted with Sildenafil and Tadalafil.", "recall_initiation_date": "20210518", "center_classification_date": "20210622", "termination_date": "20230712", "report_date": "20210630", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA210913"], "brand_name": ["CEQUA"], "generic_name": ["CYCLOSPORINE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["47335-506", "47335-507"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC", "TOPICAL"], "substance_name": ["CYCLOSPORINE"], "rxcui": ["2055021", "2055026"], "spl_id": ["9db609da-42a0-42b1-87f5-020261a871ad"], "spl_set_id": ["48c3d8a3-4289-4b52-9189-58b48596095c"], "package_ndc": ["47335-506-96", "47335-507-97"], "is_original_packager": [true], "nui": ["N0000175457", "N0000175458", "N0000182141", "N0000185503"], "pharm_class_epc": ["Calcineurin Inhibitor Immunosuppressant [EPC]"], "pharm_class_moa": ["Calcineurin Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "unii": ["83HN0GTJ6D"]}, "product_type": "Drugs", "event_id": "87922", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0391-2021", "product_description": "Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512  NDC 47335-506-96", "product_quantity": "N/A", "reason_for_recall": "Subpotent and Presence of Particulates .", "recall_initiation_date": "20210507", "center_classification_date": "20210520", "termination_date": "20220617", "report_date": "20210526", "code_info": "Lot #  10009, exp. date 03/2022 10006, exp. date 01/2022"}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88528", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0895-2021", "product_description": "Aconitum Napellus 12X Fear* 87% Alcohol HPUS: packaged in 30 mL containers; WHP Homeopathic Medicine, Washington Homeopathic Products 260 JR Hawvermale Way, Berkeley Springs, WV 25411.", "product_quantity": "562 bottles", "reason_for_recall": "Out-of-specification test results obtained for identification testing based on HPTLC analysis.", "recall_initiation_date": "20210820", "center_classification_date": "20210929", "termination_date": "20220621", "report_date": "20211006", "code_info": "Lot # 26198"}, {"status": "Ongoing", "city": "Skillman", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88288", "recalling_firm": "Johnson & Johnson Consumer, Inc.", "address_1": "199 Grandview Rd", "address_2": "N/A", "postal_code": "08558-1311", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in US", "recall_number": "D-0839-2021", "product_description": "Neutrogena Ultra Sheer body mist sunscreen BROAD SPECTRUM SPF 100+, Avobenzone (3%), Homosalate (15%), Octisalate (5%), Octocrylene (10%), Oxybenzone (15%), NET WT. 5.0 OZ (141 g) aerosol can, Distributed by: JOHNSON & JOHNSON CONSUMER INC. Skillman, NJ 08858, UPC 0 86800 10041 6", "product_quantity": "3,985,392 cans", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20210714", "center_classification_date": "20210924", "report_date": "20211006", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88693", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "494 patients/consumers received prescriptions and are located in AZ, CA FL, MN, MT, TX, and UT.", "recall_number": "D-0055-2022", "product_description": "BENZALKONIUM CHLORIDE 0.013% SOLUTION, Rx only, Red Mountain Compounding Rx", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns", "recall_initiation_date": "20210813", "center_classification_date": "20211026", "termination_date": "20230412", "report_date": "20211103", "code_info": "all lots within expiry"}, {"status": "Terminated", "city": "Mainland", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M021"], "brand_name": ["NATIVE"], "generic_name": ["POTASSIUM NITRATE, SODIUM FLUORIDE"], "manufacturer_name": ["The Procter & Gamble Manufacturing Company"], "product_ndc": ["69423-903"], "product_type": ["HUMAN OTC DRUG"], "route": ["DENTAL"], "substance_name": ["POTASSIUM NITRATE", "SODIUM FLUORIDE"], "rxcui": ["1038800"], "spl_id": ["3bb2cacd-330d-eec8-e063-6394a90aa6d5"], "spl_set_id": ["c1fb31f9-bbb1-71ee-e053-2a95a90abb2d"], "package_ndc": ["69423-903-41"], "is_original_packager": [true], "unii": ["RU45X2JN0Z", "8ZYQ1474W7"], "upc": ["037000288039"]}, "product_type": "Drugs", "event_id": "87944", "recalling_firm": "Accupac, Inc.", "address_1": "1501 Industrial Boulevard", "address_2": "N/A", "postal_code": "19451", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Naitonwide in the US and Puerto Rico.", "recall_number": "D-0598-2021", "product_description": "Native Fluoride Toothpaste for Sensitive Teeth, with Fluoride, 5% potassium nitrate, 0.243% sodium fluoride (0.14% w/v fluoride ion), Net Wt. 4.1 oz.,116 g, , Distr by Native, San Francisco, CA 94111  NDC: 69423-903-41, UPC 0 37000 28803 9", "product_quantity": "2,261 cases/24 tubes per case = 54,264 tubes", "reason_for_recall": "Labeling: Not Elsewhere Classified; the primary label (tube) may be incorrectly labeled as Fluoride-Free instead of With Fluoride", "recall_initiation_date": "20210513", "center_classification_date": "20210526", "termination_date": "20210811", "report_date": "20210602", "code_info": "LOT 0317M107 with expiry Oct 12 2022  LOT1075M107 with expiry Feb 16 2023"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0150-2022", "product_description": "TEST CYPIONATE 200MG/ANASTROZOLE 0.25MG/DUTASTERIDE 1MG/ML IN OIL  INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "2 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: T1006032021:64 BUD: 11/30/2021", "more_code_info": ""}, {"status": "Ongoing", "city": "Elmwood Park", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87751", "recalling_firm": "QMart", "address_1": "495 Mola Blvd", "address_2": "N/A", "postal_code": "07407-2041", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0371-2021", "product_description": "Imperial Platinum 2000, 1 capsule, UPC 718122040702", "product_quantity": "200 boxes", "reason_for_recall": "Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and/or sildenafil.", "recall_initiation_date": "20210331", "center_classification_date": "20210506", "report_date": "20210512", "code_info": "All"}, {"status": "Ongoing", "city": "Tonala", "state": "N/A", "country": "Mexico", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86898", "recalling_firm": "GAZA PROVEEDORA DE SERVICIOS DE HOSPEDAJE Y ALIMENTACION", "address_1": "Castilla 1473a Coloniajardines De", "address_2": "Tonala", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "TX", "recall_number": "D-0230-2021", "product_description": "Zapien Productos Hand Sanitizer Gel Antibacterial, 33.8 FL. OZ (1000 mL), Made by GAZA S.A. DE C.V. Castilla St. #1473-A ZIP 45410 Tonala, Jalisco, Mexico, UPC: 7 501700 623504, NDC numbers: 76938-001-01, 76938-001-02, 76938-001-03.", "product_quantity": "43875 liters", "reason_for_recall": "cGMP deviations: Product made at the same facility where product tested was sub-potent.", "recall_initiation_date": "20201201", "center_classification_date": "20210114", "report_date": "20210120", "code_info": "All Lots"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87981", "recalling_firm": "Miracle 8989", "address_1": "2001 W Northwest Hwy", "address_2": "N/A", "postal_code": "75220-2350", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0633-2021", "product_description": "PremierZEN Gold 7000 capsule, 1-count blister card, packaged in 12 cards per box (UPC 7 28175 42183 2), Distributed by: New Premier Group, Los Angeles, CA  90006", "product_quantity": "Unknown", "reason_for_recall": "Marketed without an approved NDA/ANDA - Product found to be tainted with Sildenafil and Tadalafil.", "recall_initiation_date": "20210518", "center_classification_date": "20210622", "termination_date": "20230712", "report_date": "20210630", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075600"], "brand_name": ["PODOFILOX"], "generic_name": ["PODOFILOX"], "manufacturer_name": ["Padagis US LLC"], "product_ndc": ["0574-0611"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["PODOFILOX"], "rxcui": ["582926"], "spl_id": ["e75d3f9f-dd11-4c3e-9e6e-3d9af2cd76da"], "spl_set_id": ["6af07697-5203-43e0-ba35-83683af851c3"], "package_ndc": ["0574-0611-05"], "is_original_packager": [true], "nui": ["N0000008732"], "pharm_class_pe": ["Decreased Mitosis [PE]"], "unii": ["L36H50F353"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0549-2021", "product_description": "Podofilox Topical Solution 0.5% 3.5ML, Rx Only, For Topical Use Only, Manufactured by Perrigo, Minneapolis, MN 55427, NDC 0574-0611-05.", "product_quantity": "180 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "402995"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA200909"], "brand_name": ["EZETIMIBE AND SIMVASTATIN"], "generic_name": ["EZETIMIBE AND SIMVASTATIN"], "manufacturer_name": ["Dr.Reddys Laboratories Inc"], "product_ndc": ["43598-742", "43598-744", "43598-743", "43598-745"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["EZETIMIBE", "SIMVASTATIN"], "rxcui": ["476345", "476349", "476350", "476351"], "spl_id": ["697ae8a7-2359-455f-9c21-e266f1c31288"], "spl_set_id": ["023ca87a-1b04-8c17-dc4f-e2758b0771e2"], "package_ndc": ["43598-742-30", "43598-742-90", "43598-742-10", "43598-744-30", "43598-744-90", "43598-744-10", "43598-743-30", "43598-743-90", "43598-743-05", "43598-745-30", "43598-745-90", "43598-745-05"], "is_original_packager": [true], "upc": ["0343598745909", "0343598742908", "0343598743905", "0343598744902"], "nui": ["N0000175589", "N0000000121", "N0000008553", "N0000175911"], "pharm_class_epc": ["HMG-CoA Reductase Inhibitor [EPC]", "Dietary Cholesterol Absorption Inhibitor [EPC]"], "pharm_class_moa": ["Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"], "pharm_class_pe": ["Decreased Cholesterol Absorption [PE]"], "unii": ["AGG2FN16EV", "EOR26LQQ24"]}, "product_type": "Drugs", "event_id": "88798", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0083-2022", "product_description": "Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/80 mg, a) 30 count (NDC 43598-745-30), b) 90 count (NDC 43598-745-90), and c) 500 count (NDC 43598-745-05) bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106, USA, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 USA", "product_quantity": "a) 3,444 bottles b) 469 bottles c) 142 bottles", "reason_for_recall": "Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivity", "recall_initiation_date": "20211005", "center_classification_date": "20211029", "termination_date": "20230216", "report_date": "20211110", "code_info": "a) L100160, exp 01/2023 b) L100249, exp 01/2023 c) L100250, exp 01/2023"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0198-2021", "product_description": "labetalol HCl  20 mg/4 mL, Injection for Intravenous Use (5mg/mL), Rx Only, 4 mL Single Dose Syringe, SCA Pharmaceuticals, 755 Rainbow Rd.,  Windsor, CT, 06095,  barcode 70004070028", "product_quantity": "9,057 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot # 1220022969, BUD 3/1/2021; 1220023002, BUD 3/2/2021;  1220023045, BUD 3/2/2021; 1220023081, BUD 3/2/2021;  1220023130, BUD 3/6/2021;  1220023229, BUD 3/9/2021;  1220023287, BUD 3/12/2021 &  1220023335, BUD 3/22/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA076667"], "brand_name": ["FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI"], "generic_name": ["FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI"], "manufacturer_name": ["CVS Pharmacy"], "product_ndc": ["69842-249"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["FEXOFENADINE HYDROCHLORIDE", "PSEUDOEPHEDRINE HYDROCHLORIDE"], "rxcui": ["997406"], "spl_id": ["de0cfc4c-d1e7-4c5e-1d66-89beb495dc27"], "spl_set_id": ["d106f6b3-36df-e926-c298-b030dc79dbe6"], "package_ndc": ["69842-249-20", "69842-249-30"], "original_packager_product_ndc": ["55111-447"], "unii": ["2S068B75ZU", "6V9V2RYJ8N"]}, "product_type": "Drugs", "event_id": "89042", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "N/A", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide.", "recall_number": "D-0268-2022", "product_description": "Allergy & Congestion Relief Allergy Relief D, Fexofenadine HCl 60 mg/ Pseudoephedrine HCl 120 mg Extended Release Tablets, 20 extended-release tablets, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, Made in India, NDC 69842-249-20", "product_quantity": "14976 cartons", "reason_for_recall": "Failed dissolution specifications", "recall_initiation_date": "20211112", "center_classification_date": "20211207", "termination_date": "20230623", "report_date": "20211215", "code_info": "Lot #: AC2103329I, Exp 1/2023", "more_code_info": ""}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0169-2022", "product_description": "TESTOSTERONE CYPIONATE 100MG/ML INJ #1 IN ETHYL OLEATE INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "168 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: T0204272021:49 BUD: 10/24/2021; T0206142021:55 BUD: 12/11/2021; T0209082021:74 BUD: 03/07/2022; T0506212021:52 BUD: 12/18/2021; T0207082021:41 BUD: 01/04/2022; T0208112021:07 BUD: 02/07/2022; T0206012021:26 BUD: 11/28/2021; T0507122021:00 BUD: 01/08/2022; T0505112021:58 BUD: 11/07/2021; T0205182021:56 BUD: 11/14/2021; T0506102021:88 BUD: 12/07/2021; T0508182021:56 BUD: 02/14/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88515", "recalling_firm": "Prescription Labs Inc dba Greenpark", "address_1": "4061f Bellaire Blvd", "address_2": "N/A", "postal_code": "77025-1121", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0804-2021", "product_description": "Spironolactone Ophthalmic Solution 0.005 mg/mL, 15 mL bottles, Rx only, Greenpark Compounding Pharmacy", "product_quantity": "350 bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20210818", "center_classification_date": "20210916", "termination_date": "20230815", "report_date": "20210922", "code_info": "Lots: 03012021@35; 04132021@10; 05102021@12; 06012021@28; 07012021@25; 03012021@36; 04132021@12; 05102021@11; 06012021@29; 07132021@14; 03152021@9; 06162021@21; 07132021@16; 03152021@10; 06162021@22", "more_code_info": ""}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0221-2022", "product_description": "TRI-MIX PAPAVERINE 30/PHENTOLAMINE 4/PGE-1 5 INJ   INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "1 vial", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 05192021:49 BUD: 10/23/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Fairview", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87324", "recalling_firm": "Adams.Secret.co", "address_1": "29-31 Industrial Ave", "address_2": "N/A", "postal_code": "07022-1625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0310-2021", "product_description": "Adam's Secret Extra Strength 1500, 800 mg, 10 count blister packs, Distributed by KP Inc., Made in USA, UPC 6 09728 43462 5", "product_quantity": "218 boxes", "reason_for_recall": "Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of  tadalafil and sildenafil.", "recall_initiation_date": "20210215", "center_classification_date": "20210319", "termination_date": "20220420", "report_date": "20210331", "code_info": "All lots within expiry.", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87298", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA and Puerto Rico.", "recall_number": "D-0282-2021", "product_description": "MethyIPREDNISolone Acetate Injectable Suspension USP, 400 mg/10 mL (40 mg/mL), 10 mL Multiple-Dose Vial, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA  19454, NDC 0703-0045-01.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.", "recall_initiation_date": "20210210", "center_classification_date": "20210221", "termination_date": "20240515", "report_date": "20210303", "code_info": "Lot # 31327725B, exp. date 02/2021  Lot # 31327906B, exp. date 03/2021"}, {"status": "Terminated", "city": "Venice", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87828", "recalling_firm": "Scentsational Soaps & Candles Inc", "address_1": "730 Commerce Dr", "address_2": "N/A", "postal_code": "34292-1726", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0683-2021", "product_description": "Goose Creek Hand Sanitizer aloe Tropical Daydream, Anti-Bacterial Spray, 3.38 FL. OZ. (100 mL), Goose Creek www.GooseCreekCandle.com, 1498 S. Wallace Wilkinson Blvd., Liberty, KY 42539, UPC 8 18489 01335 6", "product_quantity": "1,260 bottles", "reason_for_recall": "Chemical contamination: product found to be contaminated with methanol (wood alcohol), benzene and acetaldehyde.", "recall_initiation_date": "20210427", "center_classification_date": "20210719", "termination_date": "20221202", "report_date": "20210728", "code_info": "Lot #: 20260", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0546-2021", "product_description": "Fexofenadine Hydrochloride Tablets, 180 mg Antihistamine Non-Drowsy 100 Tablets 180 mg Each NDC 45802-571-78 Distributed By Perrigo Allegan, MI 49010", "product_quantity": "321 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88738", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0025-2022", "product_description": "AirDuo Digihaler 232/14 (fluticasone propionate 232 mcg and salmeterol 14 mcg) Inhalation Powder, Rx Only, Mktd by: Teva Respiratory, LLC, Frazer, PA 19355, Manufactured in Ireland, NDC 59310-136-06", "product_quantity": "5,500 inhalers", "reason_for_recall": "Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol", "recall_initiation_date": "20210922", "center_classification_date": "20211021", "termination_date": "20230216", "report_date": "20211027", "code_info": "AFR18A"}, {"status": "Terminated", "city": "Oklahoma City", "state": "OK", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203835"], "brand_name": ["LOSARTAN POTASSIUM"], "generic_name": ["LOSARTAN POTASSIUM"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."], "product_ndc": ["43063-854"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LOSARTAN POTASSIUM"], "rxcui": ["979492"], "spl_id": ["302a7ff6-a449-db29-e063-6294a90a87b6"], "spl_set_id": ["abb56236-f2fe-45b5-93ac-35fd661f8992"], "package_ndc": ["43063-854-60", "43063-854-90", "43063-0854-90"], "original_packager_product_ndc": ["31722-701"], "upc": ["0343063854907"], "unii": ["3ST302B24A"]}, "product_type": "Drugs", "event_id": "87774", "recalling_firm": "PD-Rx Pharmaceuticals, Inc.", "address_1": "727 N Ann Arbor Ave", "address_2": "N/A", "postal_code": "73127-5822", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "AK, AZ, CA, CO, FL, KY, MA, MI, MN, NC, OH, OR, WI, WY", "recall_number": "D-0341-2021", "product_description": "Losartan Potassium USP, 50 mg, RX Only,  Pkg By PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 a) 60 Tablets NDC: 43063-854-60; b) 90 Tablets NDC: 43063-0854-90", "product_quantity": "576 bottles", "reason_for_recall": "CGMP deviation: Product found to contain trace amounts of NMBA", "recall_initiation_date": "20190308", "center_classification_date": "20210426", "termination_date": "20210616", "report_date": "20210505", "code_info": "Lots: A19B99 Exp. 11/30/2019; B19A26 Exp. 11/30/2019; B19A69 Exp. 11/30/2019; E18F12 Exp.: 09/30/19; F18A12 Exp.: 09/30/19; F18F06 Exp.: 09/30/19; G18B43 Exp.: 09/30/19; G18C43 Exp.: 09/30/19; G18F75 Exp.: 09/30/19; H18D55 Exp.: 09/30/19; I18A11 Exp.: 09/30/19; I18E32 Exp.: 09/30/19; J18A90 Exp.: 09/30/19; J18D50 Exp. 11/30/2019; L18D01 Exp. 11/30/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88693", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "494 patients/consumers received prescriptions and are located in AZ, CA FL, MN, MT, TX, and UT.", "recall_number": "D-0028-2022", "product_description": "Calcium Chloride, 100 mg/mL MDV INJ, Rx only, Red Mountain Compounding Rx", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns", "recall_initiation_date": "20210813", "center_classification_date": "20211026", "termination_date": "20230412", "report_date": "20211103", "code_info": "all lots within expiry"}, {"status": "Ongoing", "city": "Elmwood Park", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87751", "recalling_firm": "QMart", "address_1": "495 Mola Blvd", "address_2": "N/A", "postal_code": "07407-2041", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0370-2021", "product_description": "Burro en Primavera, 2 capsules, UPC 638632431055", "product_quantity": "500 boxes", "reason_for_recall": "Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and/or sildenafil.", "recall_initiation_date": "20210331", "center_classification_date": "20210506", "report_date": "20210512", "code_info": "All"}, {"status": "Ongoing", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3", "68968-5553-1"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "87980", "recalling_firm": "Noven Pharmaceuticals Inc", "address_1": "11960 Sw 144th St", "address_2": "N/A", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0394-2021", "product_description": "Daytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours (1.6 mg/hr), 30 Patches (NDC 68968-5553-1) per box (NDC 68968-5553-3), Rx only, Manufactured for Noven Therapeutics, LLC., Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186.", "product_quantity": "6,689 boxes", "reason_for_recall": "Defective Delivery System: The number of customer complaints for ripping patches and tight release/adhesive transfer have exceeded the action limits.", "recall_initiation_date": "20210520", "center_classification_date": "20210524", "report_date": "20210602", "code_info": "Lot: 88530 Exp. 10/2021"}, {"status": "Terminated", "city": "Memphis", "state": "TN", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "88340", "recalling_firm": "People's Custom Rx and Clinical Care, LLC", "address_1": "785 E Brookhaven Cir", "address_2": "N/A", "postal_code": "38117-4501", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "MS, TN", "recall_number": "D-0718-2021", "product_description": "C-PROGESTERONE OIL 100 MG/ML, 10 mL vials, Compound, People's Custom Rx, Compounded, Rx only, People's Custom Rx, 785 E Brookhaven Cir, Memphis, TN  38117", "product_quantity": "14 vials", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20210511", "center_classification_date": "20210809", "termination_date": "20240820", "report_date": "20210818", "code_info": "Lot: 11649 BUD: 07/07/2021"}, {"status": "Terminated", "city": "Colchester", "state": "VT", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "87514", "recalling_firm": "Edge Pharma, LLC", "address_1": "856 Hercules Dr", "address_2": "N/A", "postal_code": "05446-8014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "PA only", "recall_number": "D-0307-2021", "product_description": "Epinephrine/Lidocaine HCl, Sterile Ophthalmic Solution for Injection, 0.8 mL per syringe, Single Use Syringe, 0.025%/0.75%, Rx only, Edge Pharma LLC 856 Hercules Dr. Colchester, VT 05446, NDC 05446-0863-01", "product_quantity": "60 syringes", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date", "recall_initiation_date": "20201222", "center_classification_date": "20210318", "termination_date": "20210610", "report_date": "20210324", "code_info": "Lot #: 10-2020-13@8, exp. date 12/03/2020"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0181-2022", "product_description": "TESTOSTERONE CYPIONATE 20MG/ML INJ #1 IN ETHYL OLEATE INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "7 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: T0507152021:64 BUD: 01/11/2022; T0507232021:35 BUD: 01/19/2022; T0507292021:15 BUD: 01/25/2022", "more_code_info": ""}, {"status": "Ongoing", "city": "Anaheim", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87833", "recalling_firm": "Preferred Pharmaceuticals, Inc.", "address_1": "1250 N Lakeview Ave Ste O", "address_2": "N/A", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Distributed to two physician consignees located in FL.", "recall_number": "D-0385-2021", "product_description": "Preferred Pharmaceuticals Inc., Metformin HCl, Extended Release Tab. USP 500 mg, Generic for Glucophage XR, Rx Only, Pkg Size: 100, Mfg: Time-Cap Labs Inc.; Farmingdale NY, NDC #: 68788-6932-1", "product_quantity": "147 bottles (14,700 extended release tablets)", "reason_for_recall": "CMGP Deviations: Presence of NDMA impurity detected in product and exceed the Acceptable Daily Intake Limit (ADI) of 96ng/day.", "recall_initiation_date": "20210428", "center_classification_date": "20210516", "report_date": "20210526", "code_info": "Lot Codes: C2520W,Exp.12/31/2021; E0620F, Exp. 12/31/2021; G2020M, Exp. 4/30/2022; G2720A, Exp. 4/30/2022"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"brand_name": ["ENBRACE HR"], "generic_name": ["LEVOMEFOLATE MAGNESIUM, LEUCOVORIN, FOLIC ACID, FERROUS CYSTEINE GLYCINATE, MAGNESIUM ASCORBATE, ZINC ASCORBATE, COCARBOXYLASE, FLAVIN ADENINE DINUCLEOTIDE, NADH, PYRIDOXAL PHOSPHATE ANHYDROUS, COBAMAMIDE, BETAINE, MAGNESIUM L-THREONATE, 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, AND PHOSPHATIDYL SERINE"], "manufacturer_name": ["Jaymac Pharma"], "product_ndc": ["64661-650"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM", "1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM", "BETAINE", "COBAMAMIDE", "COCARBOXYLASE", "FERROUS CYSTEINE GLYCINATE", "FLAVIN ADENINE DINUCLEOTIDE", "FOLIC ACID", "LEUCOVORIN", "LEVOMEFOLATE MAGNESIUM", "MAGNESIUM ASCORBATE", "MAGNESIUM L-THREONATE", "NADH", "PHOSPHATIDYL SERINE", "PYRIDOXAL PHOSPHATE ANHYDROUS", "ZINC ASCORBATE"], "spl_id": ["136a126c-9b1e-4258-9785-cc6959ef6a0f"], "spl_set_id": ["6f14fa40-97ab-4ec5-b66b-793d6d1abac9"], "package_ndc": ["64661-650-30"], "is_original_packager": [true], "upc": ["0364661650302"], "nui": ["N0000175804", "N0000175805", "N0000178369", "M0008658"], "pharm_class_moa": ["Methylating Activity [MoA]"], "pharm_class_epc": ["Methylating Agent [EPC]", "Folate Analog [EPC]"], "pharm_class_cs": ["Folic Acid [CS]"], "unii": ["6WJM73T46K", "9ABD9DRK7B", "3SCV180C9W", "F0R1QK73KB", "Q57971654Y", "8B4OP7RK5N", "ZC44YTI8KK", "935E97BOY8", "Q573I9DVLP", "1VZZ62R081", "0N1G678593", "1Y26ZZ0OTM", "4J24DQ0916", "394XK0IH40", "F06SGE49M6", "9TI35313XW"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0496-2021", "product_description": "Enbrace HR 30 ct. Softgels Enhanced Prenatal Vitamin Supplement Rx NDC 64661-650-30 Manufactured for: JAYMAC Pharmaceuticals, LLC, Sunset, LA 70584", "product_quantity": "11 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0444-2021", "product_description": "BENZEFOAM EMOLLIENT FOAM BENZOYL PEROXIDE 5.3% 100GM TOP EMOL NDC 187-0194--10; OTC; FOAMS", "product_quantity": "2 carton", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA020832"], "brand_name": ["CHLORAPREP ONE-STEP"], "generic_name": ["CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL"], "manufacturer_name": ["CareFusion 213, LLC"], "product_ndc": ["54365-400"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CHLORHEXIDINE GLUCONATE", "ISOPROPYL ALCOHOL"], "rxcui": ["858726", "998282"], "spl_id": ["415fe396-0d2b-40a9-e063-6294a90a8462"], "spl_set_id": ["85791e13-4103-19fe-e053-2991aa0a647f"], "package_ndc": ["54365-400-38"], "is_original_packager": [true], "unii": ["MOR84MUD8E", "ND2M416302"]}, "product_type": "Drugs", "event_id": "87715", "recalling_firm": "CareFusion 213, LLC", "address_1": "1550 Northwestern Dr", "address_2": "", "postal_code": "79912-8000", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0373-2021", "product_description": "BD ChloraPrep Hi-Lite Orange 26 mL Applicator (2% w/v chlorhexidine gluconate (CHG) and 70% v/v Isopropyl alcohol (IPA)) Sterile Solution, CareFusion 213, LLC, El Paso, TX 79912, subsidiary of Becton, Dickinson and Co, NDC 54365-400-38", "product_quantity": "707,050 eaches", "reason_for_recall": "Defective Delivery System: An increase in complaints identified endcap being loose or falling off upon activation releasing glass shards containing the solution.", "recall_initiation_date": "20210420", "center_classification_date": "20210510", "termination_date": "20230621", "report_date": "20210519", "code_info": "Lot #: 0108186, Exp. 4/30/2023; 0327867, 0327868, 0328213, 0338656, 0339071, 0328947, 0328949, 0329475, 0329477, 0330457, 0330955, 0330606   0333826, 0333852, 0333855, 0334119, 0335787, 0335792, 0335029, 0336506   0336972, 0336051, 0337245, 0337025, 0338653, 0338542, 0338852, 0339892   0339457, Exp. 11/30/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88693", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "494 patients/consumers received prescriptions and are located in AZ, CA FL, MN, MT, TX, and UT.", "recall_number": "D-0061-2022", "product_description": "METHYLCOBALAMIN 5000MCG/ML MDV INJ, Rx only, Red Mountain Compounding Rx", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns", "recall_initiation_date": "20210813", "center_classification_date": "20211026", "termination_date": "20230412", "report_date": "20211103", "code_info": "all lots within expiry"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0205-2022", "product_description": "TRI-MIX PAPAVERINE 30/PHENTOLAMINE 1/PGE-1 2.5 INJ   INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "30 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 07222021:11 BUD: 11/30/2021; 08172021:72 BUD: 02/08/2022; 06282021:84 BUD: 10/23/2021; 07132021:93 BUD: 10/23/2021; 09102021:43 BUD: 02/08/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Waltham", "state": "MA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA020171"], "brand_name": ["DELFLEX"], "generic_name": ["DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE"], "manufacturer_name": ["Fresenius Medical Care North America"], "product_ndc": ["49230-206", "49230-209", "49230-212"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAPERITONEAL"], "substance_name": ["CALCIUM CHLORIDE", "DEXTROSE MONOHYDRATE", "MAGNESIUM CHLORIDE", "SODIUM CHLORIDE", "SODIUM LACTATE"], "spl_id": ["38fafec0-59d7-1a67-e063-6294a90a8f1e"], "spl_set_id": ["bbc5b820-4973-11e2-a192-0002a5d5c51b"], "package_ndc": ["49230-206-20", "49230-206-30", "49230-206-32", "49230-206-50", "49230-206-60", "49230-206-62", "49230-206-52", "49230-209-23", "49230-209-30", "49230-209-32", "49230-209-50", "49230-209-60", "49230-209-62", "49230-209-52", "49230-212-23", "49230-212-30", "49230-212-32", "49230-212-50", "49230-212-60", "49230-212-62", "49230-212-52"], "is_original_packager": [true], "unii": ["LX22YL083G", "451W47IQ8X", "M4I0D6VV5M", "02F3473H9O", "TU7HW0W0QT"]}, "product_type": "Drugs", "event_id": "87907", "recalling_firm": "Fresenius Medical Care Holdings, Inc.", "address_1": "920 Winter St Bld 950", "address_2": "N/A", "postal_code": "02451-1521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0610-2021", "product_description": "DELFLEX Peritoneal Dialysis Solution with 1.5% Dextrose, Low magnesium, Low Calcium, packaged in a) 3000 mL bags (NDC 49230-206-30)  and b) 5000mL bags, 2 packs (NDC 49230-206-50), Rx only, Fresenius Medical Care NA, Waltham, MA 02451", "product_quantity": "285 cases", "reason_for_recall": "Temperature Abuse: Product exposed to temperature outside specified limits.", "recall_initiation_date": "20210428", "center_classification_date": "20210609", "termination_date": "20210917", "report_date": "20210616", "code_info": "Lot #: a) 20SU03060, Exp Date. July 2022; b) 21AU02015, 21AU02038, Exp. Date August 2022"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "87373", "recalling_firm": "Noven Pharmaceuticals Inc", "address_1": "11960 Sw 144th St", "address_2": "", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0294-2021", "product_description": "Daytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours (1.6 mg/hr), Contains: 30 Patches in in a foil-sealed polypropylene tray,  packed in a paper carton, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL, 33186, By Noven Pharmaceuticals, Inc., Miami, FL, 33186, NDC 68968-5553-3.", "product_quantity": "551,670 patches", "reason_for_recall": "Defective Delivery System: Out of specification for mechanical peel.", "recall_initiation_date": "20210219", "center_classification_date": "20210303", "termination_date": "20240705", "report_date": "20210310", "code_info": "Lots #: 87818, Exp 4/2021, 88274, Exp 5/2021 & 88531, Exp 7/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA200909"], "brand_name": ["EZETIMIBE AND SIMVASTATIN"], "generic_name": ["EZETIMIBE AND SIMVASTATIN"], "manufacturer_name": ["Dr.Reddys Laboratories Inc"], "product_ndc": ["43598-742", "43598-744", "43598-743", "43598-745"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["EZETIMIBE", "SIMVASTATIN"], "rxcui": ["476345", "476349", "476350", "476351"], "spl_id": ["697ae8a7-2359-455f-9c21-e266f1c31288"], "spl_set_id": ["023ca87a-1b04-8c17-dc4f-e2758b0771e2"], "package_ndc": ["43598-742-30", "43598-742-90", "43598-742-10", "43598-744-30", "43598-744-90", "43598-744-10", "43598-743-30", "43598-743-90", "43598-743-05", "43598-745-30", "43598-745-90", "43598-745-05"], "is_original_packager": [true], "upc": ["0343598745909", "0343598742908", "0343598743905", "0343598744902"], "nui": ["N0000175589", "N0000000121", "N0000008553", "N0000175911"], "pharm_class_epc": ["HMG-CoA Reductase Inhibitor [EPC]", "Dietary Cholesterol Absorption Inhibitor [EPC]"], "pharm_class_moa": ["Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"], "pharm_class_pe": ["Decreased Cholesterol Absorption [PE]"], "unii": ["AGG2FN16EV", "EOR26LQQ24"]}, "product_type": "Drugs", "event_id": "88798", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0085-2022", "product_description": "Dr. Reddy's  Ezetimibe and Simvastatin Tablets, 10 mg/40 mg, 500 count bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106, USA, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 USA NDC 43598-743-05", "product_quantity": "696 bottles", "reason_for_recall": "Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle", "recall_initiation_date": "20211005", "center_classification_date": "20211029", "termination_date": "20230216", "report_date": "20211110", "code_info": "L100208, exp 01/2023"}, {"status": "Terminated", "city": "Longview", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "88291", "recalling_firm": "Med Shop Total Care Inc.", "address_1": "470 E Loop 281", "address_2": "N/A", "postal_code": "75605-7939", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Texas and Puerto Rico", "recall_number": "D-0715-2021", "product_description": "MORPHINE-BUPIVACAINE-FENTANYL PF 30MG-15MG-2000MCG/ML INJECTABLE 21 mL syringe, Rx only,  Med Shop Total Care 470 East Loop 281 Longview, TX 75605", "product_quantity": "21 mL", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20201005", "center_classification_date": "20210809", "termination_date": "20230817", "report_date": "20210818", "code_info": "Lot #: 09302020@57  BUD 10/29/2020"}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["BLA020986"], "brand_name": ["NOVOLOG"], "generic_name": ["INSULIN ASPART"], "manufacturer_name": ["Novo Nordisk"], "product_ndc": ["0169-2100", "0169-7501", "0169-3303", "0169-6339", "0169-6338", "0169-2001", "0169-2101"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["INSULIN ASPART"], "rxcui": ["311040", "351926", "1653196", "1653198", "1653202", "1653204"], "spl_id": ["de82c22d-ea25-44ef-8bcd-c3cda9e84e59"], "spl_set_id": ["3a1e73a2-3009-40d0-876c-b4cb2be56fc5"], "package_ndc": ["0169-7501-11", "0169-7501-90", "0169-3303-12", "0169-3303-91", "0169-3303-90", "0169-6339-10", "0169-6339-90", "0169-6339-97", "0169-6339-98", "0169-6338-10", "0169-6338-90", "0169-6338-97", "0169-2001-90", "0169-2100-11", "0169-2101-12", "0169-2101-25"], "is_original_packager": [true], "nui": ["M0011417", "N0000175453"], "pharm_class_cs": ["Insulin [CS]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "unii": ["D933668QVX", "059QF0KO0R"]}, "product_type": "Drugs", "event_id": "87537", "recalling_firm": "Novo Nordisk Inc", "address_1": "800 Scudders Mill Rd", "address_2": "N/A", "postal_code": "08536-1606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0616-2021", "product_description": "NovoLog (Insulin aspart) Injection, 100 units/mL (U-100), One 10 mL multi-dose vial, Sample. Not for Resale, Rx Only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark  NDC 0169-7501-90", "product_quantity": "N/A", "reason_for_recall": "Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.", "recall_initiation_date": "20210322", "center_classification_date": "20210610", "termination_date": "20221209", "report_date": "20210421", "code_info": "JZFC826 exp 06/30/2021;   KZFM305 exp 08/31/2022"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0479-2021", "product_description": "ARNUITY ELLIPTA 100MCG 30INH; NDC/UPC 173087410; RX; INHALER MEDICAL INTERNAL - MAY OR MAY NOT BE AEROSOL", "product_quantity": "513 inhalers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "F79E"}, {"status": "Terminated", "city": "Georgetown", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87363", "recalling_firm": "Areva Pharmaceuticals Inc", "address_1": "7112 Areva Dr Ne", "address_2": "N/A", "postal_code": "47122-7953", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0270-2021", "product_description": "Irinotecan Hydrochloride Injection, USP, 40 mg/2 mL (20 mg/mL), 2 mL Single-Dose Vial, Rx Only, Distributed by: Areva Pharmaceuticals, Inc., Gerogetown, IN 47122, Made in India, NDC 59923-714-02.", "product_quantity": "3287 vials", "reason_for_recall": "CGMP Deviations: based on a Warning Letter received by the manufacturer of the recalled product for inadequate out-of specification investigations, complaint and the investigation conclusions.", "recall_initiation_date": "20201119", "center_classification_date": "20210221", "termination_date": "20221228", "report_date": "20210303", "code_info": "Lot 7S10022A, Exp Jan-21"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0521-2021", "product_description": "PEDIA-LAX 66ML; NDC/UPC 301320202205; OTC; ENEMA", "product_quantity": "147", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "87373", "recalling_firm": "Noven Pharmaceuticals Inc", "address_1": "11960 Sw 144th St", "address_2": "", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0293-2021", "product_description": "Daytrana (methylphenidate transdermal system), Delivers 10 mg over 9 hours (1.1 mg/hr), Contains: 30 Patches in a foil-sealed polypropylene tray, packed in a paper carton, Rx only,  Manufactured for Noven Therapeutics, LLC, Miami, FL, 33186, By Noven Pharmaceuticals, Inc., Miami, FL, 33186,  NDC 68968-5552-3.", "product_quantity": "473,280 patches", "reason_for_recall": "Defective Delivery System: Out of specification for mechanical peel.", "recall_initiation_date": "20210219", "center_classification_date": "20210303", "termination_date": "20240705", "report_date": "20210310", "code_info": "Lots #: 87579, Exp 3/2021 & 88243, Exp 7/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090355"], "brand_name": ["THEOPHYLLINE"], "generic_name": ["THEOPHYLLINE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-356", "68462-380"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["THEOPHYLLINE ANHYDROUS"], "rxcui": ["313291", "348472"], "spl_id": ["aaa6684e-4eef-42a8-92b6-8f317e570903"], "spl_set_id": ["56fc2167-ceb6-4e3e-8ff7-5e400dfbd533"], "package_ndc": ["68462-380-01", "68462-380-05", "68462-356-01", "68462-356-05"], "is_original_packager": [true], "upc": ["0368462380017", "0368462356012"], "nui": ["N0000175790", "M0023046"], "pharm_class_epc": ["Methylxanthine [EPC]"], "pharm_class_cs": ["Xanthines [CS]"], "unii": ["0I55128JYK"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0485-2021", "product_description": "Theophylline (Anhydrous) Extended-Release Tablets 400 mg 100 Tablets Rx Only NDC 68462-380-01 Manufactured by: Glenmark Pharmaceuticals Limited Colvale-Bardez, Goa 403513, India Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430", "product_quantity": "141 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "19205025"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0195-2021", "product_description": "HYDROmorphone HCl 6 mg/30mL in 0.9% Sodium Chloride Injection (0.2 mg/mL), Rx Only, a) 30 mL Plungerless Single Dose Syringe (barcode 70004030016) and b) 30 mL Single Dose Syringe (barcode 70004030018), SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095", "product_quantity": "3,092 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "a) Lot # 1220023171, BUD 1/26/2021; 1220023282, BUD 2/1/2021; 1220023446, BUD 2/7/2021; 1220023532, BUD 2/8/2021; 1220023650, BUD 2/11/2021 & 1220023727, BUD 2/14/2021.  b) Lot # 1220023241, BUD 1/25/2021; 1220023313, BUD 2/1/2021 & 1220023442, BUD 2/7/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Ronkonkoma", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88322", "recalling_firm": "Spirit Pharmaceuticals", "address_1": "2004 Orville Dr N Ste 2", "address_2": "N/A", "postal_code": "11779-7645", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0729-2021", "product_description": "Acetaminophen 325 mg tablets, Regular Strength Pain Reliever, 100-count bottle, Distributed by: Walmart Inc., Bentoville, AR 72716, NDC 79903-052-10", "product_quantity": "N/A", "reason_for_recall": "cGMP deviations: Discolored acetaminophen", "recall_initiation_date": "20210616", "center_classification_date": "20210816", "termination_date": "20220907", "report_date": "20210825", "code_info": "Lot #: S210240, Exp. 03/2023"}, {"status": "Terminated", "city": "Waltham", "state": "MA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA020171"], "brand_name": ["DELFLEX"], "generic_name": ["DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE"], "manufacturer_name": ["Fresenius Medical Care North America"], "product_ndc": ["49230-206", "49230-209", "49230-212"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAPERITONEAL"], "substance_name": ["CALCIUM CHLORIDE", "DEXTROSE MONOHYDRATE", "MAGNESIUM CHLORIDE", "SODIUM CHLORIDE", "SODIUM LACTATE"], "spl_id": ["38fb023a-a8db-cd70-e063-6394a90a14f9"], "spl_set_id": ["c29bdfa0-4976-11e2-939b-0002a5d5c51b"], "package_ndc": ["49230-206-92", "49230-206-94", "49230-206-95", "49230-209-92", "49230-209-94", "49230-209-95", "49230-212-92", "49230-212-94", "49230-212-95"], "is_original_packager": [true], "unii": ["LX22YL083G", "451W47IQ8X", "M4I0D6VV5M", "02F3473H9O", "TU7HW0W0QT"]}, "product_type": "Drugs", "event_id": "87907", "recalling_firm": "Fresenius Medical Care Holdings, Inc.", "address_1": "920 Winter St Bld 950", "address_2": "N/A", "postal_code": "02451-1521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0607-2021", "product_description": "DELFLEX Peritoneal Dialysis Solution with 1.5% Dextrose, Low magnesium, Low Calcium and attached stay safe Exchange set, 2000 mL Fresenius Medical Care NA, Waltham, MA 02451, NDC 49230-206-92", "product_quantity": "5 cases", "reason_for_recall": "Temperature Abuse: Product exposed to temperature outside specified limits.", "recall_initiation_date": "20210428", "center_classification_date": "20210609", "termination_date": "20210917", "report_date": "20210616", "code_info": "Lot #: 20SU02032, Exp. date July 2022"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["ROMPE PECHO"], "generic_name": ["DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL"], "manufacturer_name": ["Efficient Laboratories Inc"], "product_ndc": ["58593-235"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["DEXTROMETHORPHAN HYDROBROMIDE", "GUAIFENESIN", "PHENYLEPHRINE HYDROCHLORIDE"], "rxcui": ["1044949"], "spl_id": ["3e6375e6-6668-3453-e063-6394a90add02"], "spl_set_id": ["96c4dee1-6e66-4442-a7e3-56e874414c17"], "package_ndc": ["58593-235-06", "58593-235-04", "58593-235-08", "58593-235-29", "58593-235-10"], "is_original_packager": [true], "nui": ["N0000193956", "N0000008867", "N0000009560"], "pharm_class_epc": ["Expectorant [EPC]"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "unii": ["9D2RTI9KYH", "495W7451VQ", "04JA59TNSJ"]}, "product_type": "Drugs", "event_id": "89205", "recalling_firm": "Efficient Laboratories, Inc.", "address_1": "7715 NW 64th St", "address_2": "N/A", "postal_code": "33166-2719", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0290-2022", "product_description": "Rompe Pecho CF Cold & Flu Advanced Formula, 6 Fl. oz. (178 mL) bottles,  Distributed by: Efficient Laboratories, Inc. Miami, FL 33166, NDC 58593-235-06", "product_quantity": "10,833 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products", "recall_initiation_date": "20210824", "center_classification_date": "20211222", "termination_date": "20221208", "report_date": "20211229", "code_info": "Lot #: 19F88 Exp. June 2022; 19G164 Exp. July 2022."}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0206-2021", "product_description": "Rocuronium Br 100 mg/10mL (10 mg/mL), Rx Only, 10 mL Single Dose Syringe, SCA Pharmaceuticals, 8821 Knoedl Ct. Little Rock, AR, 72205, barcode 70004085012", "product_quantity": "7,940 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot # 1220022998, BUD 1/21/2021; 1220023115,  BUD 1/25/2021; 1220023163, BUD 1/26/2021; 1220023186, BUD 1/27/2021; 1220023234, BUD 1/31/2021; 1220023393, BUD 2/3/2021; 1220023477, BUD 2/4/2021;  1220023568, BUD 2/9/2021 & 1220023625, BUD 2/11/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Camarillo", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA200909"], "brand_name": ["EZETIMIBE AND SIMVASTATIN"], "generic_name": ["EZETIMIBE AND SIMVASTATIN"], "manufacturer_name": ["Golden State Medical Supply"], "product_ndc": ["51407-190", "51407-191", "51407-192", "51407-193"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["EZETIMIBE", "SIMVASTATIN"], "rxcui": ["476345", "476349", "476350", "476351"], "spl_id": ["0c7b8b84-3a6b-7cb1-e063-6294a90a42a4"], "spl_set_id": ["88cd0e7b-e8dc-6125-e053-2a95a90aaa27"], "package_ndc": ["51407-190-30", "51407-190-90", "51407-190-10", "51407-191-30", "51407-191-90", "51407-191-10", "51407-192-30", "51407-192-90", "51407-192-05", "51407-192-10", "51407-193-30", "51407-193-90", "51407-193-05"], "original_packager_product_ndc": ["43598-742", "43598-744", "43598-743", "43598-745"], "nui": ["N0000175589", "N0000000121", "N0000008553", "N0000175911"], "pharm_class_epc": ["HMG-CoA Reductase Inhibitor [EPC]", "Dietary Cholesterol Absorption Inhibitor [EPC]"], "pharm_class_moa": ["Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"], "pharm_class_pe": ["Decreased Cholesterol Absorption [PE]"], "unii": ["AGG2FN16EV", "EOR26LQQ24"]}, "product_type": "Drugs", "event_id": "88866", "recalling_firm": "Golden State Medical Supply Inc.", "address_1": "5187 Camino Ruiz", "address_2": "N/A", "postal_code": "93012-8601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed to two distributors located in AZ and MO", "recall_number": "D-0228-2022", "product_description": "Ezetimibe and Simvastatin Tablets, 10 mg/80mg, 500 tablet bottles, Rx only, Manufactured by Dr. Reddy's Laboratories LA LLC Shreveport, LA 71106 USA, Packaged by GSMS, Incorporated Camarillo, CA 93012 USA; NDC 51407-193-05", "product_quantity": "49", "reason_for_recall": "Failed Excipient Specification; product manufactured using an excipient found to be OOS for conductivity", "recall_initiation_date": "20211014", "center_classification_date": "20211109", "termination_date": "20221110", "report_date": "20211117", "code_info": "GS040048, Exp: 1/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076238"], "brand_name": ["BALZIVA"], "generic_name": ["NORETHINDRONE AND ETHINYL ESTRADIOL"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0555-9034"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["238015", "748797", "749736", "1095362"], "spl_id": ["7885d65c-3e23-4a03-9d1b-132893517c04"], "spl_set_id": ["36a282d2-7285-442b-9574-dfce2d9456f1"], "package_ndc": ["0555-9034-79", "0555-9034-58"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0579-2021", "product_description": "Balziva 28 Day (norethindrone and ethinyl estradiol tablets USP)  6 Blister Card Dispensers, 28 tablets each, Rx Only, Manufactured for:  Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0555-9034-58", "product_quantity": "23 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "100016785"}, {"status": "Ongoing", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88377", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0769-2021", "product_description": "Erythromycin Topical Solution USP, 2%, 60mL bottle, Rx only, Teligent Pharma, Inc. Buena, NJ 08310, NDC 52565-027-59", "product_quantity": "7488 bottles", "reason_for_recall": "Defective container: possibility for lack of seal integrity.", "recall_initiation_date": "20210729", "center_classification_date": "20210825", "report_date": "20210901", "code_info": "Lot #: 14892, Exp 1/2022"}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88528", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0873-2021", "product_description": "Althaea 6X, Iritable Bladder* Sucrose/Lactose Pills, packaged as 1 OZ, WHP Homeopathic Medicine, Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411.", "product_quantity": "10 bottles", "reason_for_recall": "Out-of-specification test results obtained for identification testing based on HPTLC analysis.", "recall_initiation_date": "20210820", "center_classification_date": "20210929", "termination_date": "20220621", "report_date": "20211006", "code_info": "Lot # 29377, Exp 8/17/2026"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0129-2022", "product_description": "MIC B COMPLEX INJ-MILES FORMULATION INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "1 vial", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 08112021:46 BUD: 11/09/2021", "more_code_info": ""}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0165-2022", "product_description": "TEST CYPIONATE 200MG/DUTASTERIDE 0.5MG/ML IN OIL  INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "21 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: T1006042021:53 BUD: 12/01/2021; T1008192021:83 BUD: 02/15/2022; T1005212021:52 BUD: 11/17/2021; T1009072021:35 BUD: 03/06/2022; T1007132021:61 BUD: 01/09/2022; T1009142021:95 BUD: 03/13/2022", "more_code_info": ""}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0213-2022", "product_description": "TRI-MIX PAPAVERINE 30/PHENTOLAMINE 2/PGE-1 40 INJ   INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "8 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 06232021:01 BUD: 10/23/2021; 08132021:58 BUD: 02/08/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0565-2021", "product_description": "HYDROCORTISONE 1% 30gm cream", "product_quantity": "143 tubes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "KK4912"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA022056"], "brand_name": ["PRILOSEC"], "generic_name": ["OMEPRAZOLE MAGNESIUM"], "manufacturer_name": ["Covis Pharma US, Inc"], "product_ndc": ["70515-610", "70515-625"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["OMEPRAZOLE MAGNESIUM"], "rxcui": ["797058", "797061", "797063", "797065"], "spl_id": ["296db0e8-af6e-4053-874d-2a7c8f7aba50"], "spl_set_id": ["b6761f84-53ac-4745-a8c8-1e5427d7e179"], "package_ndc": ["70515-625-01", "70515-610-01"], "is_original_packager": [true], "unii": ["426QFE7XLK"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0466-2021", "product_description": "Prilosec (Omeprazole Magnesium) For Delayed-Release Oral Suspension 10 mg Rx only NDC 70515-610-01 Mfd. for: Covis Pharma, Zug, 6300 Switzerland", "product_quantity": "13 packets", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "CACU"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0196-2022", "product_description": "TRI-MIX PAPAVERINE 25MG/PHENTOLAMINE 1MG/PGE1 25MCG/ML INJ   INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "1 vial", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 08312021:13 BUD: 02/08/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Plattsburgh", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88436", "recalling_firm": "SterRx, LLC", "address_1": "141 Idaho Ave", "address_2": "N/A", "postal_code": "12903-3987", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0768-2021", "product_description": "Sodium Bicarbonate in 5% Dextrose Injection, 150 mEq per 1,000 mL (12.6 mg per mL), 1,000 mL bags, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903", "product_quantity": "3378 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20210810", "center_classification_date": "20210825", "termination_date": "20220519", "report_date": "20210901", "code_info": "Lot Numbers:    BTW, exp. date 03/08/22  BUI, exp. date 03/16/22"}, {"status": "Terminated", "city": "Whippany", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "88677", "recalling_firm": "Bayer Healthcare Pharmaceuticals Inc.", "address_1": "100 Bayer Blvd", "address_2": "N/A", "postal_code": "07981-1544", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the US, Puerto Rico, Canada and Mexico through a variety of retail channels.", "recall_number": "D-0248-2022", "product_description": "LOTRIMIN AF, (Miconazole nitrate 2%), Powder Spray, NET WT 133g (4.6 OZ) can, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Spain, NDC 11523-0544-2   UPC 3 11017 41025 7", "product_quantity": "3,816,468 cans", "reason_for_recall": "Chemical Contamination: presence of benzene", "recall_initiation_date": "20211001", "center_classification_date": "20211118", "termination_date": "20230626", "report_date": "20211124", "code_info": "Lot # CV01AP2, EXP 2/28/2022; TN006TD, EXP 3/31/2023; TN008CV, EXP 4/30/2023; TN008CW, EXP 5/31/2023;", "more_code_info": ""}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88528", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0863-2021", "product_description": "Althaea Officinalis 4X, Iritable Bladder* packaged as Sucrose/Lactose Pills, 4 Dram, WHP Homeopathic Medicine, Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411.", "product_quantity": "10 bottles", "reason_for_recall": "Out-of-specification test results obtained for identification testing based on HPTLC analysis.", "recall_initiation_date": "20210820", "center_classification_date": "20210929", "termination_date": "20220621", "report_date": "20211006", "code_info": "Lot # 29377, Exp 8/17/2026"}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88528", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0874-2021", "product_description": "Althaea 6X, Iritable Bladder* 20% Alcohol, Drops,  packaged as 15 ml, WHP Homeopathic Medicine, Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411.", "product_quantity": "10 bottles", "reason_for_recall": "Out-of-specification test results obtained for identification testing based on HPTLC analysis.", "recall_initiation_date": "20210820", "center_classification_date": "20210929", "termination_date": "20220621", "report_date": "20211006", "code_info": "Lot # 29377, Exp 8/17/2026"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076186"], "brand_name": ["AMANTADINE HYDROCHLORIDE"], "generic_name": ["AMANTADINE HYDROCHLORIDE"], "manufacturer_name": ["Upsher-Smith Laboratories, LLC"], "product_ndc": ["0832-0111"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMANTADINE HYDROCHLORIDE"], "rxcui": ["849395"], "spl_id": ["395d9ef2-7ea2-c602-e063-6394a90a6ef0"], "spl_set_id": ["63d9d4aa-5f92-45b0-98d0-d6ec38b727cb"], "package_ndc": ["0832-0111-00", "0832-0111-50", "0832-0111-89", "0832-0111-03"], "is_original_packager": [true], "unii": ["M6Q1EO9TD0"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0592-2021", "product_description": "Amantadine Hydrochloride Tablets 100 mg 100-count bottle, Rx Only Manufactured by Upsher-Smith Laboratories, Inc. Maple Grove, MN 55369, NDC 0832-0111-00", "product_quantity": "271 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "395310"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88693", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "494 patients/consumers received prescriptions and are located in AZ, CA FL, MN, MT, TX, and UT.", "recall_number": "D-0049-2022", "product_description": "TEST CYP/PROP/DECA-NAN 125MG/ML (80/10/10) IN SESAME OIL, Rx only, Red Mountain Compounding Rx", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns", "recall_initiation_date": "20210813", "center_classification_date": "20211026", "termination_date": "20230412", "report_date": "20211103", "code_info": "all lots within expiry"}, {"status": "Terminated", "city": "Louisville", "state": "CO", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "86709", "recalling_firm": "Wishgarden Herbs, Incorporated", "address_1": "321 S Taylor Ave Unit 100", "address_2": "N/A", "postal_code": "80027-3600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA, Egypt and Canada.", "recall_number": "D-0220-2021", "product_description": "Goldenseal POWDER, 0.25 oz. (7 g) plastic jars, WishGarden Herbs, Inc., Boulder, CO 80301. UPC 6 56490 64137 9", "product_quantity": "298 jars", "reason_for_recall": "Microbial Contamination of a Non-Sterile Product: Product tested positive for Cronobacter Sakazakii.", "recall_initiation_date": "20200925", "center_classification_date": "20210107", "termination_date": "20240529", "report_date": "20210106", "code_info": "P116 - Exp. 12/2020; P117 - Exp. 05/2021; P118 - Exp. 10/2021; P119 - Exp. 01/2022; P120 - Exp. 04/2022"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88442", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed Nationwide, including Puerto Rico.", "recall_number": "D-0748-2021", "product_description": "Adenosine Injection, USP, 60mg/20 mL (3 mg/mL), 20 mL single-dose vial, Rx only, Mfd in the USA for: NorthStar Rx LLC Memphis, TN 38141, NDC 16714-180-01", "product_quantity": "20,800 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20210729", "center_classification_date": "20210816", "termination_date": "20240604", "report_date": "20210825", "code_info": "Lot #: 100022401, exp. date 04/2023"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0540-2021", "product_description": "HySept Solution 0.25% Sodium Hypochlorite Solution 473 mL (16 fl. oz.) NDC 39328-063-25 Manufactured in USA Patrin Pharma, Skokie, IL 60076", "product_quantity": "236 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}]